|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C67.6 |
Malignant neoplasm of ureteric orifice
|
C676 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 54.11%
|
26.24%
|
9.54%
|
4.49%
|
1.77%
|
1.74%
|
0.69%
|
0.54%
|
0.22%
|
0.10%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C67.6*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
922
|
1,424
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
843
|
19,239
|
|
J2405
|
ONDANSETRON HCL INJECTION |
836
|
3,691
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
593
|
597
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
585
|
652
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
582
|
3,905
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
557
|
2,178
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
547
|
547
|
|
80053
|
COMPREHEN METABOLIC PANEL |
489
|
489
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
483
|
684
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
439
|
443
|
|
J7120
|
RINGERS LACTATE INFUSION |
414
|
508
|
|
C1769
|
GUIDE WIRE |
409
|
571
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
401
|
943
|
|
52235
|
CYSTOSCOPY AND TREATMENT |
374
|
374
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
361
|
21,491
|
|
C1758
|
CATHETER, URETERAL |
335
|
402
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
334
|
690
|
|
52234
|
CYSTOSCOPY AND TREATMENT |
306
|
306
|
|
C2617
|
STENT, NON-COR, TEM W/O DEL |
302
|
327
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C67.6 related to the following DRG Codes:
656-658
686-688
|
